Loading...

Gilead Sciences, Inc. Peer Comparison

Metric Value Ranking
Market Cap $128.8 Billion 8/9 LLY
$828.7B
JNJ
$373.8B
ABBV
$341.1B
AZN
$230.8B
MRK
$216.7B
AMGN
$158.6B
PFE
$144.3B
GILD
$128.8B
BMY
$113.9B
Gross Margin -100% 9/9 LLY
82%
MRK
80%
AZN
77%
BMY
75%
ABBV
71%
PFE
70%
JNJ
70%
AMGN
61%
GILD
-100%
Profit Margin 17% 5/9 AMGN
33%
LLY
33%
PFE
25%
MRK
19%
GILD
17%
JNJ
12%
ABBV
11%
AZN
11%
BMY
10%
EBITDA margin 12% 9/9 ABBV
49%
LLY
45%
BMY
38%
JNJ
32%
PFE
31%
AZN
30%
MRK
25%
AMGN
24%
GILD
12%
Quarterly Revenue $7.6 Billion 9/9 JNJ
$22.5B
PFE
$17.7B
MRK
$16.7B
ABBV
$14.5B
AZN
$13.6B
LLY
$13.5B
BMY
$11.9B
AMGN
$8.5B
GILD
$7.6B
Quarterly Earnings $1.3 Billion 8/9 PFE
$4.5B
LLY
$4.4B
MRK
$3.2B
AMGN
$2.8B
JNJ
$2.7B
ABBV
$1.6B
AZN
$1.4B
GILD
$1.3B
BMY
$1.2B
Quarterly Free Cash Flow $4.5 Billion 5/9 MRK
$8.5B
PFE
$6.1B
BMY
$5.3B
ABBV
$5.2B
GILD
$4.5B
AMGN
$3.3B
AZN
$2.0B
JNJ
-$0
LLY
-$0
Trailing 4 Quarters Revenue $28.3 Billion 9/9 JNJ
$87.7B
MRK
$63.2B
PFE
$60.1B
ABBV
$55.5B
AZN
$51.2B
BMY
$47.4B
LLY
$45.0B
AMGN
$32.5B
GILD
$28.3B
Trailing 4 Quarters Earnings $126.0 Million 8/9 JNJ
$22.5B
PFE
$17.7B
MRK
$16.7B
ABBV
$14.5B
AZN
$13.6B
LLY
$13.5B
BMY
$11.9B
AMGN
$8.5B
GILD
$7.6B
Quarterly Earnings Growth -43% 8/9 PFE
287%
LLY
101%
AMGN
64%
AZN
4%
ABBV
-12%
MRK
-33%
BMY
-37%
GILD
-43%
JNJ
-90%
Annual Earnings Growth -98% 8/9 LLY
425%
MRK
192%
AZN
-5%
PFE
-8%
AMGN
-28%
ABBV
-35%
JNJ
-65%
GILD
-98%
BMY
-189%
Quarterly Revenue Growth 7% 6/9 LLY
45%
PFE
34%
AMGN
23%
AZN
18%
BMY
8%
GILD
7%
JNJ
5%
ABBV
4%
MRK
4%
Annual Revenue Growth 5% 6/9 LLY
19%
PFE
17%
AMGN
17%
AZN
12%
BMY
6%
GILD
5%
MRK
3%
ABBV
0%
JNJ
-10%
Cash On Hand $0 7/9 MRK
$14.6B
AMGN
$9.0B
BMY
$7.9B
ABBV
$7.3B
AZN
$4.8B
PFE
$1.1B
GILD
-$0
JNJ
-$0
LLY
-$0
Short Term Debt $0 7/9 ABBV
$12.6B
AMGN
$3.5B
MRK
$3.1B
PFE
$2.9B
AZN
$1.6B
BMY
$1.1B
GILD
-$0
JNJ
-$0
LLY
-$0
Long Term Debt $0 7/9 ABBV
$58.5B
PFE
$58.0B
AMGN
$56.9B
BMY
$48.7B
MRK
$35.0B
AZN
$30.0B
GILD
$0
JNJ
$0
LLY
$0
PE 1021.84 1/9 GILD
1021.84
LLY
78.26
ABBV
66.51
AMGN
37.50
AZN
35.54
PFE
34.08
JNJ
25.46
MRK
17.84
BMY
-1.00
PS 4.55 4/9 LLY
18.40
ABBV
6.14
AMGN
4.88
GILD
4.55
AZN
4.51
JNJ
4.26
MRK
3.43
PFE
2.40
BMY
2.40
PB 3.01 8/9 LLY
57.87
ABBV
56.18
AMGN
21.07
BMY
6.62
AZN
5.66
JNJ
5.23
MRK
4.86
GILD
3.01
PFE
1.81
PC -1.00 7/9 PFE
132.18
AZN
48.12
ABBV
47.00
AMGN
17.60
MRK
14.85
BMY
14.43
GILD
-1.00
JNJ
-1.00
LLY
-1.00
Liabilities to Equity 0.00 7/9 ABBV
22.77
AMGN
11.07
BMY
4.46
MRK
1.64
AZN
1.57
PFE
1.38
GILD
0.00
JNJ
-1.00
LLY
-1.00
ROA 0.00 6/9 MRK
10%
AZN
6%
AMGN
5%
ABBV
4%
PFE
2%
GILD
0%
BMY
-8%
JNJ
-100%
LLY
-100%
ROE -1.00 9/9 ABBV
85%
LLY
74%
AMGN
56%
MRK
27%
JNJ
21%
AZN
16%
PFE
5%
BMY
-42%
GILD
-100%
Current Ratio 4.65 1/9 GILD
4.65
AZN
1.64
PFE
1.63
MRK
1.61
BMY
1.22
AMGN
1.09
ABBV
1.04
JNJ
0.00
LLY
0.00
Quick Ratio 0.43 1/9 GILD
1021.84
LLY
78.26
ABBV
66.51
AMGN
37.50
AZN
35.54
PFE
34.08
JNJ
25.46
MRK
17.84
BMY
-1.00
Long Term Debt to Equity -1.00 9/9 ABBV}
9.70
AMGN}
7.55
BMY}
2.84
MRK}
0.79
AZN}
0.74
PFE}
0.63
JNJ}
0.00
LLY}
0.00
GILD}
-1.00
Debt to Equity -1.00 9/9 ABBV
11.78
AMGN
8.02
BMY
2.90
MRK
0.86
AZN
0.78
PFE
0.63
JNJ
0.00
LLY
0.00
GILD
-1.00
Burn Rate 0.00 5/9 AZN
29.40
AMGN
27.29
BMY
7.85
ABBV
1.85
GILD
0.00
JNJ
0.00
LLY
0.00
PFE
-0.77
MRK
-15.04
Cash to Cap 0.00 7/9 BMY
0.07
MRK
0.07
AMGN
0.06
ABBV
0.02
AZN
0.02
PFE
0.01
GILD
0.00
JNJ
0.00
LLY
0.00
CCR 3.63 2/9 BMY
4.35
GILD
3.63
ABBV
3.33
MRK
2.69
AZN
1.42
PFE
1.36
AMGN
1.17
JNJ
0.00
LLY
0.00
EV to EBITDA 144.99 1/9 GILD}
144.99
LLY}
134.78
AMGN}
102.58
AZN}
62.79
MRK}
58.74
ABBV}
57.49
JNJ}
52.65
PFE}
36.58
BMY}
34.02
EV to Revenue 4.55 5/9 LLY
18.40
ABBV
7.29
AMGN
6.46
AZN
5.03
GILD
4.55
JNJ
4.26
MRK
3.80
PFE
3.35
BMY
3.28